The Antidote Protection platform uniting three small Czech companies – Old and Rich, MB Pharma, and VAKOS XT. These companies specialize in the development and production of advanced systems for protection against toxic substances. The Antidote Protection offers a wide range of products, including autoinjectors for rapid intramuscular administration of antidotes such as obidoxime and atropine for neutralizing nerve agents, morphine for pain relief, and diazepam for treating convulsions and anxiety and related training opportunities with produced training autoinjector.
With more than 30 years on the market, EGO Zlín is a major manufacturer and supplier of complex biological protection and decontamination systems, devices for pre-hospital care and complex solutions for emergencies. These solutions namely include:
· Rapid response and strengthening the healthcare capacities in the case of outbreaks of dangerous infections or accidents involving biological/chemical agents.
· Mobile medical centre of urgent medical care in case of mass natural disasters such as earthquakes, mass traffic/industrial accidents, war conflicts, etc.
· Decontamination of affected and intervening persons.
· Mobile shelter/medical/logistic complexes for rescuers, military units or refugee camps.
Erler-Zimmer is a leading manufacturer, providing products for tactical and medical education and simulation. We´re standing for innovative solutions for healthcare since 1950. Specializing in high-quality anatomical models, simulators, medical task trainers and debriefing systems, Erler-Zimmer is committed to advancing medical education and improving patient care.
Škála aktivit fondu se neustále rozšiřuje a dnes zajišťuje nejen rehabilitační péči v ČR nebo zahraničí, ale pomáhá s výběrem osobních asistentů, spolupracuje s renomovanými rehabilitačními ústavy nebo hledá prostředky na nadstandardní rehabilitační pomůcky, vozíky i automobily.
Nadační fond REGI Base I. pořádá i veřejné sbírky a prostřednictvím silných příběhů se snaží podpořit solidaritu s těmi, kteří pomáhali, když mohli, a nyní potřebují, aby společnost pomohla zase jim.
V neposlední řadě hledá fond cesty, jak téma pomoci „těm, kteří za nás sloužili“ dostat do širšího povědomí veřejnosti i přednáškami a nejrůznějšími většími či menšími propagačními akcemi: „Protože často pomáhá nejen samotná pomoc, ale i upozornění na potřebu této pomoci.“
Praesens Care presents BIONEAR®, a rapidly deployable medical mobile laboratory for better epidemic preparedness and biological threats.
Fast detection and identification of biological agents on the spot are of great importance in response to natural, accidental or intentional biological events: it enables to implement timely efficient counter-measures for controlling the spread of the agent and mitigating its impact. Therefore, it is crucial to bring rapidly deployable testing capacities as close as possible to the crisis area, in order to better prepare our nations and communities for the next pandemic and all other global health threats.
SERB is a growing specialty pharmaceutical company dedicated to treating patients with critical conditions, focusing on emergency care and rare diseases. SERB has one of the most comprehensive, wide-ranging antidote portfolios in the world, covering CBRN risks such as nerve agent, cyanide and heavy metal poisoning. Our medical countermeasures are mainly manufactured within Europe and exported to over 100 countries. SERB is a longstanding partner for hospitals, health authorities, governmental and non-governmental agencies, national and regional stockpiles, and therapeutic area experts.
Today SERB is fully integrated company with the experience and capabilities to acquire, develop and manufacture our medicines to the highest standards, and make them available worldwide through our secure supply chain.
SERB is one of the few companies in the world manufacturing polyclonal antibodies at a commercial scale and to rigorous enough, quality standards to satisfy regulators in all territories. For over 20 years, we’ve used this technology to produce two commercially available products. More recently, we have begun to use this platform to develop novel biologic therapies against a wide range of toxins, drugs, and viruses for use around the world.
CZE
ENG
